Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma

NCT06528769 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Leiomyosarcoma
Sarcoma

Interventions

DRUG: all-trans retinoic acid
DRUG: Cemiplimab
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic resonance imaging
PROCEDURE: Biospecimen Collection

Sponsor

Gabriel Tinoco